eMethods. Secondary Outcomes: Questionnaires
The Functional Outcomes of Sleep Questionnaire 1 (FOSQ)_ENREF_17 is a disease-specific quality of life instrument which assesses the impact of excessive daytime sleepiness on a patient's ability to perform multiple activities of daily living. It is composed of a total of 30 items within five subscales which rate the difficulty of performing a given activity on a scale of 1 (extreme difficulty) to 4 (no difficulty), and has a total score out of a possible 20 points with higher scores indicating higher levels of functioning. The Sleep Apnea Symptoms Questionnaire 2 (SASQ) consists of 14 possible symptoms of obstructive sleep apnea (OSA) and asks a patient to rate the frequency of each symptom on a 10cm visual analogue scale with a measurement taken from between 0cm (never) to 10cm (always), giving a total score out of a possible 140 points with higher scores indicating more frequent obstructive sleep apnea (OSA) symptoms. The Short-Form 36 Health Survey 3 (SF-36) is a general quality of life instrument which measures the health status of a patient and consists of 36 items within 8 subscales, each of which are scored from 0 to 100, with higher scores indicating higher levels of functioning. In the Visit-Specific Satisfaction Questionnaire 4 (VSQ-9), patients are asked to rate their level of satisfaction with nine different aspects of management by health care professionals from 0 (very dissatisfied) to 5 (very satisfied), giving a total out of a possible 5 points for each of the nine items.
Within-Trial Costs
Within-trial sleep diagnostic and treatment costs were collected and compared during the 6 month follow-up period and included: (1) nurse consultations, based on recorded contact time with patients; (2) Primary care physician (PCP) and sleep physician consultations based on 2011 schedule fees for related Medicare Benefits Schedule 5 (MBS, Medicare Australia) item numbers; (3) travel costs, estimated from approximate distance from the patients' geographical region and location of the health care professional or sleep centre; (4) sleep study costs (i.e. home oximetry, laboratory-based full night diagnostic polysomnography [PSG], split night PSG and full night continuous positive airway pressure [CPAP] titration studies) based on 2011 schedule fees for related MBS item numbers; and (5) treatment-related costs (i.e. CPAP hire or purchase, humidifiers, masks and chin straps used, and mandibular advancement splint [MAS] costs). In Australia, it is usual practice for patients to hire CPAP equipment for a period of time after initiation of therapy until acceptance of therapy, at which time a CPAP device is purchased. Therefore, we assumed a CPAP hire cost for patients who ceased CPAP use prior to study completion, and a CPAP purchase cost for patients who continued to use CPAP beyond the 6 month study period.
Within-study costs were also calculated for the US context and reported in US dollars. Costs for PCP and sleep physician consultations and sleep studies were based on equivalent item numbers reported within the US Centers for Medicare and Medicaid Services 2011 Medicare Fee Schedule 6 . The cost for nurse consultations were based on the average standard hourly rate for a registered nurse in the US and CPAP equipment costs were based on US recommended retail prices provided by Philips-Respironics and ResMed. All other costs were directly converted from Australian to US dollars at a conversion rate of AUD1.00 = USD1.05 7 . eTable 1. Baseline characteristics of patients who withdrew from the study compared to those who completed the study protocol to 6 months Australian costs: Sleep study and physician costs based on Medicare Australia Medicare Benefits Schedule 5 (2011) item numbers: 12203 for laboratory-based diagnostic polysomnography (PSG), split night study or full night CPAP titration ($565.75); 11503 to estimate the cost for home oximetry ($136.06); 23 for level B (<20 minute) consultations with PCP ($34.90); 110 for initial sleep physician visits ($125.90); and 116 for subsequent sleep physician visits ($72.65). Nurse costs were based on the average standard hourly rate for a registered practice nurse in Australia ($38.00/hour). Travel costs were based on the 2011 Australian Taxation Office guidelines for reimbursement of travel costs. CPAP hire costs were estimated from costs provided by several CPAP retail outlets in Adelaide, South Australia, Australia. CPAP device (fixed pressure), humidifier, mask and chin strap costs were estimated from Australian recommended retail prices provided by Philips-Respironics and ResMed. MAS costs were provided by co-author (N Vowles), a dentist experienced in providing treatment with SomnoDent MAS for OSA. . Nursing costs were based on the average standard hourly rate for a registered nurse in the US ($36.00/hour). CPAP device (fixed pressure), humidifier and chin strap costs were estimated from US recommended retail prices provided by Philips-Respironics and ResMed. All other costs were directly converted from AUD to USD using the conversion rate of AUD1.00=USD1.05 (http://www.xe.com, accessed on 27 November 2012). *Based on recorded contact time with patients during the trial **Based on actual patient visits at baseline, 3 and 6 months. # 3 patients in the primary care arm were referred to see a sleep physician during the study, 1 of whom underwent a laboratorybased full night diagnostic PSG.
